Cargando…
‘Off-the-Shelf’ Immunotherapy: Manufacture of CD8(+) T Cells Derived from Hematopoietic Stem Cells
Cellular immunotherapy is revolutionizing cancer treatment. However, autologous transplants are complex, costly, and limited by the number and quality of T cells that can be isolated from and expanded for re-infusion into each patient. This paper demonstrates a stromal support cell-free in vitro met...
Autores principales: | Boyd, Nicholas, Cartledge, Kellie, Cao, Huimin, Evtimov, Vera, Pupovac, Aleta, Trounson, Alan, Boyd, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534391/ https://www.ncbi.nlm.nih.gov/pubmed/34685611 http://dx.doi.org/10.3390/cells10102631 |
Ejemplares similares
-
Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
por: Islam, Rasa, et al.
Publicado: (2021) -
CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies
por: To, Van, et al.
Publicado: (2022) -
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
por: Shu, Runzhe, et al.
Publicado: (2021) -
Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy
por: Shu, Runzhe, et al.
Publicado: (2023) -
Toward the development of true “off‐the‐shelf” synthetic T‐cell immunotherapy
por: Iriguchi, Shoichi, et al.
Publicado: (2019)